866-997-4948(US-Canada Toll Free)

Phylogica Ltd - Product Pipeline Review - 2016

Published By :

Global Markets Direct

Published Date : Dec 2016

Category :

Pharmaceutical

No. of Pages : 29 Pages

Phylogica Ltd - Product Pipeline Review - 2016

Summary

Global Markets Directs, Phylogica Ltd - Product Pipeline Review - 2016, provides an overview of the Phylogica Ltds pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Phylogica Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Phylogica Ltd
- The report provides overview of Phylogica Ltd including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Phylogica Ltds pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Phylogica Ltds out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Phylogica Ltds strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Phylogica Ltd
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Phylogica Ltds pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Phylogica Ltd Snapshot 6
Phylogica Ltd Overview 6
Key Facts 6
Phylogica Ltd - Research and Development Overview 7
Key Therapeutic Areas 7
Phylogica Ltd - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Phylogica Ltd - Pipeline Products Glance 12
Phylogica Ltd - Early Stage Pipeline Products 12
Preclinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
Phylogica Ltd - Drug Profiles 14
PYC-35 - Drug Profile 14
Product Description 14
Mechanism Of Action 14
R&D Progress 14
PYC-36 - Drug Profile 15
Product Description 15
Mechanism Of Action 15
R&D Progress 15
PYC-38 - Drug Profile 16
Product Description 16
Mechanism Of Action 16
R&D Progress 16
PYC-98 - Drug Profile 17
Product Description 17
Mechanism Of Action 17
R&D Progress 17
Synthetic Peptide for Gram-Negative Bacterial Infection - Drug Profile 18
Product Description 18
Mechanism Of Action 18
R&D Progress 18
Synthetic Peptide to Inhibit C-Myc for Oncology - Drug Profile 19
Product Description 19
Mechanism Of Action 19
R&D Progress 19
Synthetic Peptide to Inhibit N-Myc for Oncology - Drug Profile 20
Product Description 20
Mechanism Of Action 20
R&D Progress 20
Synthetic Peptide to Inhibit STAT5A for AML and Breast Cancer - Drug Profile 21
Product Description 21
Mechanism Of Action 21
R&D Progress 21
Synthetic Peptide to Inhibit YB-1 for AML and Breast Cancer - Drug Profile 22
Product Description 22
Mechanism Of Action 22
R&D Progress 22
Phylogica Ltd - Pipeline Analysis 23
Phylogica Ltd - Pipeline Products by Target 23
Phylogica Ltd - Pipeline Products by Molecule Type 24
Phylogica Ltd - Pipeline Products by Mechanism of Action 25
Phylogica Ltd - Dormant Projects 26
Phylogica Ltd - Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 28
Methodology 28
Coverage 28
Secondary Research 28
Primary Research 28
Expert Panel Validation 28
Contact Us 28
Disclaimer 29

List of Tables
Phylogica Ltd, Key Facts 6
Phylogica Ltd - Pipeline by Indication, 2016 9
Phylogica Ltd - Pipeline by Stage of Development, 2016 10
Phylogica Ltd - Monotherapy Products in Pipeline, 2016 11
Phylogica Ltd - Preclinical, 2016 12
Phylogica Ltd - Discovery, 2016 13
Phylogica Ltd - Pipeline by Target, 2016 23
Phylogica Ltd - Pipeline by Molecule Type, 2016 24
Phylogica Ltd - Pipeline Products by Mechanism of Action, 2016 25
Phylogica Ltd - Dormant Developmental Projects,2016 26
Phylogica Ltd, Other Locations 27
Phylogica Ltd, Subsidiaries 27

List of Figures
Phylogica Ltd - Pipeline by Indication, 2016 8
Phylogica Ltd - Pipeline by Stage of Development, 2016 10
Phylogica Ltd - Monotherapy Products in Pipeline, 2016 11
Phylogica Ltd - Pipeline by Target, 2016 23
Phylogica Ltd - Pipeline by Molecule Type, 2016 24
Phylogica Ltd - Pipeline Products by Mechanism of Action, 2016 25

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *